跳至主要内容
临床试验/JPRN-jRCTs061180081
JPRN-jRCTs061180081进行中(未招募)2 期

Preoperative chemoradiothrepy for lower advanced rectal cancer patients using TS-1+Oxaliplatin+Bevacizumab regimen (phase 2 study).

Shimada Mitsuo0 个研究点目标入组 47 人开始时间: 2019年3月20日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
47

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • Patients satisfied fully with below criteria
  • 1) Diagnosed as adenocarcinoma
  • 2) cT2~T4 and cN0~N3, resectable case
  • 3) Tumor location (including Rb region)
  • 4) Measurable tumor
  • 5) No peritoneal dissemination
  • 6) No distant metastasis
  • 7) 20~80 years old
  • 8) Performance status 0~2
  • 9) Patinets with normal organ function
  • 10) No pre treatment
  • 11) Patientss with informed consent
  • 12) Patients able to take foods orally

排除标准

  • 1) Interstitial pneumonia
  • 2) Much ascites or pleural effusion
  • 3) Double cancer or treated cancer less than 5 years disease free survival
  • 4) Strong stenosis(fiber cannot pass through)
  • 5) Peritoneal dissemination
  • 6) Infection,Ileus
  • 7) Severe diarrhea
  • 8) Severe diabete mellitus
  • 9) Severe hyper tension
  • 10)Heart failure,liver failure,renal failure
  • 11) Past history of thrombosis
  • 12) Intraabdominal inflammation
  • 13) Severe paresthesia or perceived failure
  • 14) Brain metastasis
  • 15) Congenital hemorrhagic disorder or blood coagulation disorder
  • 16) Psychiatric disorder
  • 17) Pregnant woman or patients hoping of pregnancy
  • 18) Past history of severe drug allergy
  • 19) Contraindication of each trial drugs
  • 20) Past history of drug allergy for each trial drugs
  • 21) Continuous steroids administration
  • 22) Patients with anti-coagulant drugs
  • 23) Patients ncompatible with this trial judged by medical staff

研究者

发起方
Shimada Mitsuo

相似试验